Literature DB >> 25940057

Regional thrombolysis with tenecteplase during extracorporeal membrane oxygenation: a new approach for left ventricular thrombosis.

Fabio Sangalli1, Gianluca Greco1, Lucia Galbiati1, Francesco Formica2, Serena Calcinati1, Leonello Avalli1.   

Abstract

We present the case of a woman assisted with veno-arterial extracorporeal membrane oxygenation (v-a ECMO) for postischemic cardiogenic shock, who developed left ventricular thrombosis despite systemic anticoagulation and left ventricular apical venting. We successfully achieved local thrombolysis with tenecteplase administered through the venting cannula to obtain local thrombolysis while reducing systemic effects to a minimum. The procedure was effective with mild systemic bleeding and the patient was successfully weaned off the extracorporeal support a few days thereafter.
© 2015 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25940057     DOI: 10.1111/jocs.12556

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  4 in total

Review 1.  Review of Venoarterial Extracorporeal Membrane Oxygenation and Development of Intracardiac Thrombosis in Adult Cardiothoracic Patients.

Authors:  Brittney Williams; Wendy Bernstein
Journal:  J Extra Corpor Technol       Date:  2016-12

2.  A case of a giant cell myocarditis that developed massive left ventricular thrombus during percutaneous cardiopulmonary support.

Authors:  Yusuke Takei; Yutaka Ejima; Hiroaki Toyama; Kana Takei; Takahisa Ota; Masanori Yamauchi
Journal:  JA Clin Rep       Date:  2016-11-29

3.  Right Sided Intracardiac Thrombosis during Veno-Arterial Extracorporeal Membrane Oxygenation: A Case Report and Literature Review.

Authors:  Anusha Ganapati Bhat; Armand Golchin; Deepak Kumar Pasupula; Jaime A Hernandez-Montfort
Journal:  Case Rep Crit Care       Date:  2019-01-06

4.  Successful treatment of intracardiac thrombosis in the presence of fulminant myocarditis requiring ECMO associated with COVID-19.

Authors:  Erika J Mejia; Matthew J O'Connor; Benjamin J Samelson-Jones; Constantine D Mavroudis; Therese M Giglia; Rachel Keashen; Joseph Rossano; Maryam Y Naim; Katsuhide Maeda
Journal:  J Heart Lung Transplant       Date:  2022-03-10       Impact factor: 13.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.